St. Jude Medical Announces Preliminary Fourth Quarter Financial Results And Authorization Of A $500 Million Share Repurchase Program

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced preliminary revenue results for the fourth quarter ended Jan. 3, 2015. These results will be referenced today in a presentation by St. Jude Medical Chairman, President and Chief Executive Officer Daniel J. Starks, at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco. A webcast of the presentation can be accessed live on the Investor Relations section of sjm.com, beginning at 10:30 a.m. PST.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC